Clinical trial
A Clinical Evaluation Of Adipose Derived Regenerative Cells In The Treatment Of Patients With BrEast Deformities Post Segmental Breast ResecTion (Lumpectomy) With Or Without Radiation ThErapy. A Phase IV Post Market Study.
NCT00616135 is registered in ClinicalTrials.gov with Cytori Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Clinical Evaluation Of Adipose Derived Regenerative Cells In The Treatment Of Patients With BrEast Deformities Post Segmental Breast ResecTion (Lumpectomy) With Or Without Radiation ThErapy. A Phase IV Post Market Study.
- Lead sponsor
- Cytori Therapeutics
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- June 30, 2008
- Completion date
- November 30, 2010
- Enrollment
- 71 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
breast neoplasms, carcinoma, ductal, breast, mammaplasty, mastectomy, segmental, lumpectomy, breast reconstruction,